Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $70.45 USD
Change Today 0.00 / 0.00%
Volume 0.0
SHPGF On Other Exchanges
SHPGF is not on other exchanges.
As of 8:10 PM 11/23/15 All times are local (Market data is delayed by at least 15 minutes).

Transactions by SHIRE PLC (SHPGF) in the last 6 months

Announced 08/4/15
30.91B for Baxalta Incorporated

Shire plc (LSE:SHP) made an offer to acquire Baxalta Incorporated (NYSE:BXLT) from Baxter International Inc. (NYSE:BAX), BlackRock, Inc. (NYSE:BLK) and others for approximately $30 billion in stock on July 10, 2015. As part of consideration, Shire offered 0.1687 ADR shares for each share of Baxalta. As a result of transaction, Baxalta's shareholders will hold approximately 37% in the Shire. Shire will repurchase up to 13% of the combined post-transaction shares in two ...
Read More

SHPGF's price was unchanged after the transaction was announced on 08/4/15.
Investor / Buyer
Shire plc
Creditor / Lender
Baxter International Inc.
BlackRock, Inc.
Financial Advisor
Citigroup Inc.
The Goldman Sachs Group, Inc.
Legal Advisor
Kirkland & Ellis LLP
Announced 08/3/15
300.00M for Foresight Biotherapeutics, Inc.

Shire plc (LSE:SHP) agreed to acquire Foresight Biotherapeutics, Inc. from MHR Fund Management LLC and others for approximately $300 million in cash on August 3, 2015.The deal is subject to regulatory approval. Steven Navarro, Phoebe Mounts, Lou Beardell, Harry Robins, Randall McGeorge, Bryan Keighery, Lydia Lee, Morgan McDevitt, Squire Servance and David Brenneman of Morgan Lewis acted as legal advisor to Foresight Biotherapeutics. William J. Chudd, Cheryl Chan, Andrew ...
Read More

SHPGF's price was unchanged after the transaction was announced on 08/3/15.
Investor / Buyer
Shire plc
Creditor / Lender
MHR Fund Management LLC
Legal Advisor
Morgan, Lewis & Bockius LLP

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SHPGF:US $70.45 USD 0.00

SHPGF Competitors

Market data is delayed at least 15 minutes.

Company Last Change
CSL Ltd A$99.65 AUD -0.25
Eisai Co Ltd ¥8,195 JPY +1.00
Mylan NV $51.84 USD +0.04
Perrigo Co PLC $150.14 USD -0.49
UCB SA €83.11 EUR +0.38
View Industry Companies

Industry Analysis


Industry Average

Valuation SHPGF Industry Range
Price/Earnings 13.5x
Price/Sales 6.5x
Price/Book 4.3x
Price/Cash Flow 12.9x
TEV/Sales 6.6x

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact SHIRE PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at